Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus.
Vendeville, S., Tahri, A., Hu, L., Demin, S., Cooymans, L., Vos, A., Kwanten, L., Van den Berg, J., Battles, M.B., McLellan, J.S., Koul, A., Raboisson, P., Roymans, D., Jonckers, T.H.M.(2020) J Med Chem 63: 8046-8058
- PubMed: 32407115 
- DOI: 10.1021/acs.jmedchem.0c00226
- Primary Citation of Related Structures:  
6VKC, 6VKD, 6VKE - PubMed Abstract: 
Respiratory syncytial virus (RSV) is a seasonal virus that infects the lungs and airways of 64 million children and adults every year. It is a major cause of acute lower respiratory tract infection and is associated with significant morbidity and mortality ...